HHS awards $14.9M for Biomedical R&D to Resilience Government Services, Inc

Contract Overview

Contract Amount: $14,898,363 ($14.9M)

Contractor: Resilience Government Services, Inc.

Awarding Agency: Department of Health and Human Services

Start Date: 2007-09-28

End Date: 2011-12-31

Contract Duration: 1,555 days

Daily Burn Rate: $9.6K/day

Competition Type: FULL AND OPEN COMPETITION

Number of Offers Received: 13

Pricing Type: COST PLUS FIXED FEE

Sector: R&D

Official Description: BIOMEDICAL (BASIC)

Place of Performance

Location: ALACHUA, ALACHUA County, FLORIDA, 32615

State: Florida Government Spending

Plain-Language Summary

Department of Health and Human Services obligated $14.9 million to RESILIENCE GOVERNMENT SERVICES, INC. for work described as: BIOMEDICAL (BASIC) Key points: 1. The contract value is $14.9 million, awarded to Resilience Government Services, Inc. 2. The contract was awarded under full and open competition. 3. The primary risk is the cost-plus-fixed-fee pricing structure, which may not incentivize cost savings. 4. The sector is Research and Development in the Physical, Engineering, and Life Sciences.

Value Assessment

Rating: fair

The Cost Plus Fixed Fee (CPFF) contract type can lead to higher costs if not closely managed. Benchmarking against similar R&D contracts is difficult without more detailed cost breakdowns.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

The contract was awarded through full and open competition, suggesting a competitive bidding process. However, the CPFF structure might limit price discovery during the contract's performance.

Taxpayer Impact: Taxpayer funds are being used for R&D, with potential for significant return on investment if successful, but also risk of cost overruns.

Public Impact

Supports critical biomedical research and development efforts. Potential for advancements in health and life sciences. Contract duration of over 4 years indicates a significant project.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Cost Plus Fixed Fee pricing structure
Lack of detailed cost breakdown for benchmarking

Positive Signals

Full and open competition
Awarded to a single entity for specialized R&D

Sector Analysis

This contract falls within the R&D sector, specifically biomedical research. Spending in this area is crucial for innovation but can be subject to long development cycles and uncertain outcomes.

Small Business Impact

No information is available regarding small business participation in this contract.

Oversight & Accountability

Oversight would focus on monitoring the R&D progress and ensuring adherence to the fixed fee, while managing the variable cost components effectively.

Related Government Programs

Research and Development in the Physical, Engineering, and Life Sciences
Department of Health and Human Services Contracting
National Institutes of Health Programs

Risk Flags

Cost Plus Fixed Fee pricing
Potential for cost overruns
Long-term R&D with uncertain outcomes
Lack of small business participation noted

Frequently Asked Questions

What is this federal contract paying for?

Department of Health and Human Services awarded $14.9 million to RESILIENCE GOVERNMENT SERVICES, INC.. BIOMEDICAL (BASIC)

Who is the contractor on this award?

The obligated recipient is RESILIENCE GOVERNMENT SERVICES, INC..

Which agency awarded this contract?

Awarding agency: Department of Health and Human Services (National Institutes of Health).

What is the total obligated amount?

The obligated amount is $14.9 million.

What is the period of performance?

Start: 2007-09-28. End: 2011-12-31.

What specific biomedical advancements are expected from this contract?

The contract aims to support research and development in the physical, engineering, and life sciences within the biomedical field. Specific advancements are not detailed in the provided data but would likely relate to disease research, therapeutic development, or diagnostic tools, contributing to the broader goals of the National Institutes of Health.

What are the primary risks associated with the Cost Plus Fixed Fee contract type for this R&D project?

The primary risk with CPFF is that the contractor is reimbursed for all allowable costs plus a predetermined fixed fee. This can reduce the incentive for the contractor to control costs rigorously, potentially leading to higher overall expenditures than anticipated if not managed with strong oversight.

How does the $14.9 million award compare to typical R&D contract values in this sector?

Without specific benchmarks for 'Biomedical (Basic)' R&D contracts of this duration and scope, it's difficult to definitively assess. However, $14.9 million over 4 years is a substantial award, suggesting a significant research undertaking. Further analysis would require comparing it to similar NIH or other agency R&D contracts.

Industry Classification

NAICS: Professional, Scientific, and Technical Services › Scientific Research and Development Services › Research and Development in the Physical, Engineering, and Life Sciences

Product/Service Code: RESEARCH AND DEVELOPMENT › N – Health R&D Services

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION

Solicitation Procedures: BASIC RESEARCH

Offers Received: 13

Pricing Type: COST PLUS FIXED FEE (U)

Evaluated Preference: NONE

Contractor Details

Address: 12085 RESEARCH DR STE N, ALACHUA, FL, 32615

Business Categories: Category Business, Small Business, Special Designations, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $14,898,363

Exercised Options: $14,898,363

Current Obligation: $14,898,363

Contract Characteristics

Multi-Year Contract: Yes

Commercial Item: COMMERCIAL ITEM PROCEDURES NOT USED

Cost or Pricing Data: YES

Timeline